EvolveImmune Therapeutics

evolveimmune.com

Evolve Immune Therapeutics is pioneering a new class of precision cancer medicines aimed at delivering superior patient outcomes compared to existing anti-cancer therapies. The company focuses on overcoming CD8 T cell exhaustion in the tumor microenvironment by selectively regulating essential pathways to drive effective and durable anti-cancer immunity. Their innovative approach positions them as a next-generation immune-oncology company, developing novel trispecific T cell engagers with integrated CD2 costimulation to optimize anti-tumor immunity. Evolve Immune's ambition is to transform the lives of cancer patients and their families through advanced therapeutic solutions.